ONCOLIX, INC.
Patent Owner
Stats
- 8 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jun 17, 2014 most recent publication
Details
- 8 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 50 Total Citation Count
- Mar 23, 2001 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8754031 Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathwayMar 08, 05Jun 17, 14[A61K]
8754035 Compositions and methods for visualizing and eliminating cancer stem cellsFeb 16, 10Jun 17, 14[A61K, C07K]
8648046 Compositions and methods for visualizing and eliminating cancer stem cellsNov 17, 10Feb 11, 14[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0231,286 Use of Prolactin Receptor Antagonist and Chemotherapeutic Drug for Treating Ovarian CancerAbandonedNov 16, 11Sep 05, 13[A61K]
2010/0041,598 Use of Prolactin in the Prophylactic Treatment of CancerAbandonedOct 19, 06Feb 18, 10[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.